Bad Soden am Taunus, Germany

Gunter Regitz


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 100(Granted Patents)


Company Filing History:


Years Active: 1981-1983

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Gunter Regitz in Diabetes Treatment**

Introduction

Gunter Regitz, a noted inventor based in Bad Soden am Taunus, Germany, has made significant contributions to pharmaceutical innovations, particularly in the field of diabetes treatment. His extensive work in developing novel compounds has earned him five patents, showcasing his dedication to advancing medical science.

Latest Patents

Regitz's latest patents focus on heterocyclic substituted sulfonyl ureas, which have important applications in treating diabetes. These patents disclose sulfonyl ureas characterized by specific formulae where R¹, X, and Y represent particular groups detailed in the specifications. They also encompass physiologically acceptable salts and pharmaceutical formulations based on these compounds. Additionally, he has patented benzenesulfonyl ureas, also used in diabetes treatment, which further illustrates his innovative approach to addressing this prevalent health issue.

Career Highlights

Throughout his career, Gunter Regitz has been affiliated with Hoechst Aktiengesellschaft, where he has played a vital role in the research and development of novel pharmaceutical compounds. His expertise in chemical synthesis and innovative drug design has positioned him as a key contributor in the pharmaceutical industry, particularly in creating effective treatments for diabetes.

Collaborations

Collaboration is crucial in the field of innovation, and Regitz has worked alongside esteemed colleagues such as Rudi Weyer and Volker Hitzel. Their joint efforts have complemented Regitz's research, leading to significant advancements in the development of sulfonyl ureas and enhancing the understanding of their therapeutic potential.

Conclusion

Gunter Regitz's contributions to diabetes treatment through his patented inventions exemplify the importance of innovation in medicine. His work not only improves medical outcomes for patients but also inspires future research in pharmaceutical sciences. As he continues his journey at Hoechst Aktiengesellschaft, the impact of his inventions will undoubtedly resonate in the field of diabetes treatment for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…